ClinicalTrials.Veeva

Menu

Incorporation of a Health Equity Approach to Hospital Violence Intervention Programs: The Integration of a Community and Hospital Based Initiatives to Reduce Gun Violence in a Large Metropolitan Area

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Begins enrollment in 3 months

Conditions

Firearm Injury

Treatments

Behavioral: Standard of Care
Behavioral: Houston-HVIP treatment

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06263647
HSC-MS-23-0904
UG3NR021232 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to evaluate the effectiveness of Houston-HVIP in reducing the occurrence of repeat firearm violence among adults receiving care at Memorial Hermann Hospital in Houston,to determine the impact of the community-engaged Houston-HVIP program on violent victimization and mental and behavioral health, to assess the impact of the Houston-HVIP program on reducing racial and ethnic disparities among individuals impacted by firearm violence injury, to determine the impact of the community-engaged Houston-HVIP program on physical and behavioral health during the 12-month follow-up period and to identify the predictors of implementation success, including dosage, reach, fidelity, and acceptability from the perspective of gun violence victims, health care providers, and community violence intervention specialists.

Enrollment

274 estimated patients

Sex

All

Ages

16 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • presented for a gunshot injury stemming from community violence at Memorial Hermann Hospital
  • English or Spanish-speaking
  • provide informed voluntary consent to participate in the study
  • live in Harris County at time of enrollment

Exclusion criteria

  • presenting for a firearm injury arising from a self-inflicted gunshot or unintentional gun violence
  • actively detained by criminal justice systems at time of enrollment

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

274 participants in 2 patient groups

Houston-HVIP treatment group
Experimental group
Treatment:
Behavioral: Houston-HVIP treatment
Standard of Care group
Active Comparator group
Treatment:
Behavioral: Standard of Care

Trial contacts and locations

1

Loading...

Central trial contact

Sandra McKay, MD; Alexander Testa, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems